Back to top
more

CVS Health (CVS)

(Delayed Data from NYSE)

$66.63 USD

66.63
12,908,298

-0.22 (-0.33%)

Updated Oct 11, 2024 04:00 PM ET

After-Market: $66.63 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 7% (233 out of 250)

Industry: Retail - Pharmacies and Drug Stores

Better trading starts here.

Zacks News

Factors Likely to Influence Rite Aid's (RAD) Q1 Earnings

Strength in PBM and Elixir and expanded omnichannel services are likely to have aided Rite Aid (RAD) in Q1. However, rising pandemic costs and low testing demand are likely to have been worrisome.

CVS Health (CVS) Digital Tools Gain Steam Amid COVID-19 Crisis

CVS Health's (CVS) consumer-centric digital strategy is more relevant in the current environment as people are increasingly using technology while staying indoors.

The Zacks Analyst Blog Highlights: Apple, The Home Depot, Sanofi, Applied Materials and CVS Health

The Zacks Analyst Blog Highlights: Apple, The Home Depot, Sanofi, Applied Materials and CVS Health

CVS Health (CVS) Dips More Than Broader Markets: What You Should Know

CVS Health (CVS) closed the most recent trading day at $84.23, moving -0.6% from the previous trading session.

Sheraz Mian headshot

Top Stock Reports for Apple, Home Depot & Sanofi

Today's Research Daily features new research reports on 16 major stocks, including Apple (AAPL), The Home Depot (HD), and Sanofi (SNY).

Urmimala Biswas headshot

Amazon's Physical Pharmacy Not a Grave Threat: 3 Stocks to Buy

Investors should not lose optimism and continue to discover the enormous business opportunities this retail pharmacy- drug store industry holds. Here are three stocks, WMT, UNH, HLF, which you can grab now.

CVS Health (CVS) Introduces Changes in ExtraBucks Program

CVS Health's (CVS) retail division to offer instant 2% ExtraBucks rewards on purchases through the ExtraCare Rewards loyalty program.

CVS Health (CVS) Dips More Than Broader Markets: What You Should Know

CVS Health (CVS) closed at $84.74 in the latest trading session, marking a -0.77% move from the prior day.

Riya Anand headshot

3 Stocks With Telehealth Offerings for Post-Pandemic Gains

Stocks like CVS Health (CVS), Walgreens Boots Alliance (WBA) and Allscripts (MDRX) are expected to continue to grow post-pandemic on a series of remote health care product and service launches.

CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know

CVS Health (CVS) closed at $85.50 in the latest trading session, marking a +0.65% move from the prior day.

Federal Realty (FRT) Boosts Portfolio With Buyouts, Stock Up

Federal Realty's (FRT) recent acquisitions offer scope for value creation through redevelopment, merchandising and capital investment.

CVS Health (CVS) Deploys Time-Delay Safes in Georgia Pharmacies

CVS Health's (CVS) time-delay safes are anticipated to help reduce robbery incidents.

Here's Why You Should Retain CVS Health (CVS) in Your Portfolio

Investors are optimistic about CVS Health (CVS) on solid first-quarter performance and growth in digital health services.

Splunk (SPLK) Q1 Earnings Miss Estimates, Revenues Up Y/Y

Splunk's (SPLK) first-quarter fiscal 2022 results reflect growth in cloud revenues and customer base expansion despite decline in license revenues.

Why Is CVS Health (CVS) Up 3.6% Since Last Earnings Report?

CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Cigna (CI) Rides on Acquisitions, Strong Capital Deployment

Cigna (CI) looks well poised for growth on the back of its acquisitions, membership strength and other growth strategies.

CVS Health (CVS) Launches Clinical Trial Services Business

The latest clinical trial experience from CVS Health (CVS) is expected to overcome multiple challenges posed by its current clinical trial model.

CVS Health (CVS) Gains From Digitalization, Hurt by Seasonality

CVS Health's (CVS) consumer-centric digital strategy is now more relevant in the current environment as people are using technology while staying indoors.

Sheraz Mian headshot

Top Analyst Reports for Cisco, Sanofi & Charles Schwab

Today's Research Daily features new research reports on 16 major stocks, including Cisco Systems, Inc. (CSCO), Sanofi (SNY), and The Charles Schwab Corporation (SCHW).

The Zacks Analyst Blog Highlights: Nike, CVS Health, American Tower Corp, The Southern Co, American International Group and Parker-Hannifin Corp

The Zacks Analyst Blog Highlights: Nike, CVS Health, American Tower Corp, The Southern Co, American International Group and Parker-Hannifin Corp

Mark Vickery headshot

Top Stock Reports for Nike, CVS Health & American Tower

Today's Research Daily features new research reports on 16 major stocks, including NIKE, Inc. (NKE), CVS Health Corporation (CVS), and American Tower Corporation (AMT).

CVS Health (CVS) Gains As Market Dips: What You Should Know

CVS Health (CVS) closed the most recent trading day at $81.12, moving +4.41% from the previous trading session.

CVS Health (CVS) Q1 Earnings Beat Estimates, EPS View Up

CVS Health's (CVS) revenues across all the three operating segments improve in Q1. Increased guidance amid the pandemic scenario is another positive.

CVS Health (CVS) Q1 Earnings and Revenues Top Estimates

CVS Health (CVS) delivered earnings and revenue surprises of 18.60% and 0.96%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?